TMEM219 regulates the transcription factor expression and proliferation of beta cells

Francesca D'Addio1,2, Emma Assi1, Anna Maestroni1

  • 1International Center for Type 1 Diabetes (T1D), Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Department of Biomedical and Clinical Sciences (DIBIC), Università di Milano, Milan, Italy.

PubMed

Insights

Blocking TMEM219 preserves pancreatic beta cells by inhibiting cell death and promoting proliferation. The microRNA miR-129-2 regulates TMEM219, offering a potential therapeutic target for type 1 diabetes.

Area of Science:

  • Endocrinology and Metabolism
  • Cell Biology
  • Diabetes Research

Background:

  • Pancreatic beta cell replenishment is a key therapeutic strategy for type 1 diabetes.
  • Stimulating endogenous beta cell proliferation is crucial for patients with diminished beta cell mass.
  • TMEM219, a pro-apoptotic receptor, plays a role in regulating beta cell fate.

Purpose of the Study:

  • To investigate the role of TMEM219 in pancreatic beta cell development and survival.
  • To explore the potential of targeting TMEM219 for therapeutic benefit in type 1 diabetes.
  • To identify upstream regulators of TMEM219, specifically microRNAs, involved in beta cell regulation.

Main Methods:

  • Expression analysis of TMEM219 in fetal pancreas and embryonic endocrine progenitors.
  • Pharmacological blockade of TMEM219 in islets and in vitro-derived endocrine progenitors.
  • Investigation of the TMEM219 regulatory network, focusing on microRNA-129-2 (miR-129-2) using mimics and inhibitors.

Main Results:

  • TMEM219 is expressed in early pancreatic development and negatively regulates beta cell precursors via Caspase 8-mediated cell death.
  • TMEM219 blockade enhanced beta cell precursor markers, proliferation, and survival in vitro and in islets.
  • miR-129-2, highly expressed in human islets (especially in type 1 diabetes patients), downregulates TMEM219; conversely, miR-129-2 inhibition increases TMEM219, restoring proliferation and function in insulinoma cells.

Conclusions:

  • TMEM219 acts as a critical negative regulator of beta cell precursor development and survival.
  • Pharmacological inhibition of TMEM219 offers a promising approach for beta cell preservation and potential regeneration in type 1 diabetes.
  • The miR-129-2/TMEM219 axis represents a novel endogenous regulatory pathway controlling beta cell fate and regenerative potential.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.8K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.2K